201 related articles for article (PubMed ID: 20969640)
1. Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
Sumitomo M; Asakuma J; Sato A; Ito K; Nagakura K; Asano T
Int J Urol; 2010 Nov; 17(11):924-30. PubMed ID: 20969640
[TBL] [Abstract][Full Text] [Related]
2. Editorial Comment to Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
Uchida T
Int J Urol; 2010 Nov; 17(11):930. PubMed ID: 20969641
[No Abstract] [Full Text] [Related]
3. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
4. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
5. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
6. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
7. Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy.
Stone NN; Stone MM; Rosenstein BS; Unger P; Stock RG
J Urol; 2011 Feb; 185(2):495-500. PubMed ID: 21167528
[TBL] [Abstract][Full Text] [Related]
8. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
9. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
[TBL] [Abstract][Full Text] [Related]
10. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
11. Seven years of experience with high-intensity focused ultrasound for prostate cancer: advantages and limitations.
Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
Prostate; 2012 Sep; 72(13):1399-406. PubMed ID: 22253052
[TBL] [Abstract][Full Text] [Related]
12. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
13. Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years.
Munro NP; Al-Qaisieh B; Bownes P; Smith J; Carey B; Bottomley D; Ash D; Henry AM
Radiother Oncol; 2010 Jul; 96(1):34-7. PubMed ID: 20362348
[TBL] [Abstract][Full Text] [Related]
14. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
[TBL] [Abstract][Full Text] [Related]
15. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.
Uchida T; Illing RO; Cathcart PJ; Emberton M
BJU Int; 2006 Oct; 98(4):770-2. PubMed ID: 16879448
[TBL] [Abstract][Full Text] [Related]
16. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
17. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
18. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
19. Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role.
Chaussy CG; Thüroff S
Arch Esp Urol; 2011 Jul; 64(6):493-506. PubMed ID: 21791716
[TBL] [Abstract][Full Text] [Related]
20. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.
Uchida T; Baba S; Irie A; Soh S; Masumori N; Tsukamoto T; Nakatsu H; Fujimoto H; Kakizoe T; Ueda T; Ichikawa T; Ohta N; Kitamura T; Sumitomo M; Hayakawa M; Aoyagi T; Tachibana M; Ikeda R; Suzuki K; Tsuru N; Suzuki K; Ozono S; Fujimoto K; Hirao Y; Monden K; Nasu Y; Kumon H; Nishi K; Ueda S; Koga H; Naitoh S
Hinyokika Kiyo; 2005 Oct; 51(10):651-8. PubMed ID: 16285617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
